Absolute Requirement for an Active Immune Response Involving B Cells and Th Cells in Immunity toPlasmodium yoeliiPassively Acquired with Antibodies to the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein-1
Open Access
- 15 June 1999
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 162 (12) , 7309-7314
- https://doi.org/10.4049/jimmunol.162.12.7309
Abstract
Vaccination of mice with the leading malaria vaccine candidate homologue, the 19-kDa carboxyl terminus of merozoite surface protein-1 (MSP119), results in sterile immunity to Plasmodium yoelii, with no parasites detected in blood. Although such immunity depends upon high titer Abs at challenge, high doses of immune sera transferred into naive mice reduce parasitemia (and protect from death) but do not result in a similar degree of protection (with most mice experiencing high peak parasitemias); this finding suggests that ongoing parasite-specific immune responses postchallenge are essential. We analyzed this postchallenge response by transferring Abs into manipulated but malaria-naive mice and observed that Abs cannot protect SCID, nude, CD4+ T cell-depleted, or B cell knockout mice, with all mice dying. Thus, in addition to the Abs that develop following MSP119 vaccination, a continuing active immune response postchallenge is required for protection. MSP119-specific Abs can adoptively transfer protection to strains of mice that are not protected following vaccination with MSP119, suggesting that the Ags targeted by the immune response postchallenge include Ags apart from MSP119. These data have important implications for the development of a human malaria vaccine.Keywords
This publication has 16 references indexed in Scilit:
- Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP119) and their role in immunity to malariaParasite Immunology, 1998
- PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINEAnnual Review of Immunology, 1998
- Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.The Journal of Immunology, 1997
- Successful T cell priming in B cell-deficient mice.The Journal of Experimental Medicine, 1995
- Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.The Journal of Experimental Medicine, 1994
- Immunization against malaria with a recombinant proteinParasite Immunology, 1994
- A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain geneNature, 1991
- Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoeliiMolecular and Biochemical Parasitology, 1989
- Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.The Journal of Experimental Medicine, 1986
- Immunization against blood-stage rodent malaria using purified parasite antigensNature, 1981